David Scott Miller


AuthID: R-00K-250

Confirmed Publications: 317



51
TITLE: Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer
AUTHORS: Makker V.; Colombo N.; Casado C Herráez; Santin A.D.; Colomba E.; David Scott Miller ; Fujiwara K.; Pignata S.; Baron-Hay S.; Ray-Coquard I.; Shapira-Frommer R.; Ushijima K.; Sakata J.; Yonemori K.; Kim Y.M.; Guerra E.M.; Sanli U.A.; McCormack M.M.; Smith A.D.; Keefe S.; Bird S.; Dutta L.; Orlowski R.J.; Lorusso D.; ...More
PUBLISHED: 2022, SOURCE: New England Journal of Medicine, VOLUME: 386, ISSUE: 5
INDEXED IN: Scopus CrossRef: 513
IN MY: ORCID | CIÊNCIAVITAE
52
TITLE: Lenvatinib Plus Pembrolizumab for Advanced Endometrial Cancer
AUTHORS: Vicky Makker; Nicoletta Colombo; Antonio Casado Herráez; Alessandro D Santin; Emeline Colomba; David Scott Miller ; Keiichi Fujiwara; Sandro Pignata; Sally Baron Hay; Isabelle Ray Coquard; Ronnie Shapira Frommer; Kimio Ushijima; Jun Sakata; Kan Yonemori; Yong Man Kim; Eva M Guerra; Ulus A Sanli; Mary M McCormack; Alan D Smith; Stephen Keefe; Steven Bird; Lea Dutta; Robert J Orlowski; Domenica Lorusso; ...More
PUBLISHED: 2022, SOURCE: Journal of Bone and Joint Surgery, VOLUME: 77, ISSUE: 5
INDEXED IN: Scopus CrossRef
IN MY: ORCID | CIÊNCIAVITAE
53
TITLE: Lynch Syndrome Identification in Endometrial Cancer Patients: Should Universal Screening be Used for all Histologies?
AUTHORS: Jessica E Parker; Caitlin Mauer; Wenxin Zheng; David Scott Miller ; Jayanthi S Lea;
PUBLISHED: 2022, SOURCE: Current Women's Health Reviews, VOLUME: 18, ISSUE: 2
INDEXED IN: Scopus CrossRef
IN MY: ORCID | CIÊNCIAVITAE
54
TITLE: O018/#482 Updated safety of lenvatinib + pembrolizumab vs treatment of physician’s choice in patients with advanced endometrial cancer: study 309/keynote-775
AUTHORS: Vicky Makker; Nicoletta Colombo; Antonio Casado Herráez; Bradley Monk; Helen Mackay; Alessandro Santin; David Scott Miller ; Richard Moore; Isabelle Ray-Coquard; Ronnie Shapira-Frommer; Kimio Ushijima; Kan Yonemori; Yong Man Kim; Eva Guerra Alia; Ulus Sanli; Ran Xie; Melissa Zale; Jodi Mckenzie; Gianmaria Barresi; Domenica Lorusso;
PUBLISHED: 2022, SOURCE: Focused Plenary Abstracts
INDEXED IN: CrossRef
IN MY: ORCID | CIÊNCIAVITAE
55
TITLE: Ovarian Cancer, Version 3.2022 Featured Updates to the NCCN Guidelines. Featured Updates to the NCCN Guidelines
AUTHORS: Deborah K Armstrong; Ronald D Alvarez; Floor J Backes; Jamie N Bakkum Gamez; Lisa Barroilhet; Kian Behbakht; Andrew Berchuck; Lee May Chen; Viola C Chitiyo; Mihaela Cristea; Maria DeRosa; Eric L Eisenhauer; David M Gershenson; Heidi J Gray; Rachel Grisham; Ardeshir Hakam; Angela Jain; Amer Karam; Gottfried E Konecny; Charles A Leath; Gary Leiserowitz; Joyce Liu; Lainie Martin; Daniela Matei; Michael McHale; Karen McLean; David Scott Miller ; Sanja Percac Lima; Steven W Remmenga; John Schorge; Daphne Stewart; Premal H Thaker; Roberto Vargas; Andrea Wahner Hendrickson; Theresa L Werner; Emese Zsiros; Mary A Dwyer; Lisa Hang; ...More
PUBLISHED: 2022, SOURCE: JNCCN Journal of the National Comprehensive Cancer Network, VOLUME: 20, ISSUE: 9
INDEXED IN: Scopus CrossRef: 188
IN MY: ORCID | CIÊNCIAVITAE
56
TITLE: Pembrolizumab in pretreated advanced, metastatic cervical, vulvar, vaginal carcinoma (325)  Full Text
AUTHORS: Steven Holloway; David Scott Miller ; Jayanthi Lea;
PUBLISHED: 2022, SOURCE: Gynecologic Oncology, VOLUME: 166
INDEXED IN: CrossRef: 1
IN MY: ORCID | CIÊNCIAVITAE
57
TITLE: Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women with Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study
AUTHORS: Larry J Copeland; Mark F Brady; Robert A Burger; William H Rodgers; Helen Q Huang; David Cella; David M O'Malley; Daron G Street; Krishnansu S Tewari; David P Bender; Robert T Morris; William J Lowery; David Scott Miller ; Summer B Dewdney; Nick M Spirtos; Shashikant B Lele; Saketh Guntupalli; Frederick R Ueland; Gretchen E Glaser; Robert S Mannel; Philip J Disaia; ...More
PUBLISHED: 2022, SOURCE: Journal of Clinical Oncology, VOLUME: 40, ISSUE: 35
INDEXED IN: Scopus CrossRef: 4
IN MY: ORCID | CIÊNCIAVITAE
58
TITLE: Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial
AUTHORS: Matthew A Powell; Virginia L Filiaci; Martee L Hensley; Helen Q Huang; Kathleen N Moore; Krishnansu S Tewari; Larry J Copeland; Angeles A Secord; David G Mutch; Alessandro Santin; David P Warshal; Nick M Spirtos; Paul A DiSilvestro; Olga B Ioffe; David Scott Miller ;
PUBLISHED: 2022, SOURCE: Journal of Clinical Oncology, VOLUME: 40, ISSUE: 9
INDEXED IN: Scopus CrossRef: 48
IN MY: ORCID | CIÊNCIAVITAE
59
TITLE: Risk factors associated with 30-day postoperative complications following contemporary vulvectomies with inguinofemoral lymphadenectomies for gynecologic cancers  Full Text
AUTHORS: Alexandra Spirtos; Salvatore Lococo; Matthew Carlson; Jayanthi Lea; David Scott Miller ; Jessica Lee;
PUBLISHED: 2022, SOURCE: Gynecologic Oncology, VOLUME: 164, ISSUE: 1
INDEXED IN: CrossRef
IN MY: ORCID | CIÊNCIAVITAE
60
TITLE: 145 Characterization of adverse reactions in patients with advanced endometrial cancer (aec) receiving lenvatinib + pembrolizumab (Study 309/KEYNOTE-775)
AUTHORS: Colombo, N; Lorusso, D; AD Santin; YM Kim; AC Herráez; Yonemori, K; Fujiwara, K; Colomba, E; David Scott Miller ; Pignata, S; BJ Monk; EM Guerra; Kristeleit, R; Orlando, M; UA Sanli; Dutta, L; Orlowski, R; Ren, M; Makker, V;
PUBLISHED: 2021, SOURCE: Endometrial cancer
INDEXED IN: CrossRef: 2
IN MY: ORCID | CIÊNCIAVITAE
Page 6 of 32. Total results: 317.

footer slogan

Useful Links

Get Help

© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service